Table 2 Characteristics of diabetic patients with TASC A or B SFA lesions
|  | +TXD N = 24 | -TZD N = 87 | P-value |
|---|---|---|---|
Age | 64.45 | 68.75 | 0.11 |
Male | 79.17% | 55.17% | 0.03 |
HTN | 97.67% | 88.51% | 0.66 |
HLD | 79.17% | 81.61% | 0.78 |
CAD | 54.17% | 54.02% | 0.99 |
CKD | 17.39% | 16.09% | 0.88 |
COPD | 4.17% | 8.54% | 0.48 |
Current smoker | 12.50% | 18.39% | 0.50 |
Statin | 62.50% | 70.93 | 0.43 |
ASA | 78.26% | 82.72% | 0.63 |
Plavix | 39.13% | 44.44% | 0.65 |
Cilostazol | 8.70% | 13.58% | 0.53 |
Insulin | 50.00% | 68.97% | 0.10 |
Metformin | 37.50% | 31.03% | 0.62 |
Sulfonylurea | 27.17% | 31.03% | 0.81 |
CLI | 33.33% | 60.92% | 0.02 |
Preop toe pressure | 52.5 | 43.46 | 0.32 |
3 vessel outflow | 41.67% | 37.21% | 0.69 |